Sotera Health Company
General ticker "SHC" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $3.8B (TTM average)
Sotera Health Company follows the US Stock Market performance with the rate: 65.1%.
Estimated limits based on current volatility of 2.4%: low 16.64$, high 17.44$
Factors to consider:
- Total employees count: 3000 (0.0%) as of 2024
- US accounted for 56.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Operational and conduct risks, Supply chain disruptions, Geopolitical risks, Regulatory and compliance, Cybersecurity threats
- Price in estimated range
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [11.35$, 20.45$]
- 2025-12-31 to 2026-12-31 estimated range: [11.01$, 19.97$]
Financial Metrics affecting the SHC estimates:
- Positive: with PPE of 19.1 at the end of fiscal year the price was very low
- Positive: Operating profit margin, % of 27.05 > 18.64
- Negative: negative Industry operating cash flow (median)
- Negative: Shareholder equity ratio, % of 13.18 <= 18.93
- Negative: Investing cash flow per share per price, % of -4.72 <= -4.48
- Negative: Return on assets ratio (scaled to [-100,100]) of 1.42 <= 1.87
- Positive: Inventory ratio change, % of -0.21 <= 0
Short-term SHC quotes
Long-term SHC plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1,003.69MM | $1,049.29MM | $1,100.44MM |
| Operating Expenses | $755.34MM | $772.60MM | $802.82MM |
| Operating Income | $248.35MM | $276.69MM | $297.63MM |
| Non-Operating Income | $-491.46MM | $-170.66MM | $-183.75MM |
| Interest Expense | $80.14MM | $142.88MM | $164.69MM |
| Income(Loss) | $-243.11MM | $106.03MM | $113.87MM |
| Taxes | $-9.54MM | $54.65MM | $69.48MM |
| Profit(Loss)* | $-233.57MM | $51.38MM | $44.40MM |
| Stockholders Equity | $350.24MM | $443.73MM | $404.91MM |
| Inventory | $37.15MM | $48.32MM | $49.16MM |
| Assets | $3,117.70MM | $3,130.42MM | $3,071.65MM |
| Operating Cash Flow | $277.96MM | $-147.73MM | $224.16MM |
| Capital expenditure | $182.38MM | $214.97MM | $179.07MM |
| Investing Cash Flow | $-181.90MM | $-214.91MM | $-179.00MM |
| Financing Cash Flow | $197.76MM | $265.96MM | $-50.56MM |
| Earnings Per Share** | $-0.83 | $0.18 | $0.16 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.